Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Pediatric Enthesitis Related Arthritis
NCT01166282Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in enthesitis-related juvenile idiopathic arthritis (ERA), sponsored by AbbVie Inc.. Started Sep 2010; status: completed.
02
Drugs
03
Conditions
enthesitis-related juvenile idiopathic arthritis (ERA)
Beyond the preview
Go deeper on NCT01166282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166282.